eNews
Home page > Comments


Comments

India's Biocon expects to launch psoriasis drug by end FY13

26.07.2012. | MUMBAI (Reuters) - Biocon, India's top listed biotechnology company, expects to launch Itolizumab, a drug to treat psoriasis, by end of the current fiscal year, its Chairman Kiran Mazumdar-Shaw said....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: